3323 No. PACE IR 2020/01 Date: 25 August 2020 Subject: Explanation of the Operating Results for the three-month period ended 30 September 2019 changing over 20% To: The President The Stock Exchange of
[COMPANY NAME] Ref.: EFORL IR037/2020 September 11, 2020 Subject: Management Discussion and Analysis Quarter 2 Ending 30 June 2020 To President The Stock Exchange of Thailand 1. Overview financial
MD&A Q3_2020 (Eng ) November 2, 2020 Subject : Interim Management Discussion and Analysis of Q3/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial
Page 1 of 4 No. RJH – SET 7/2020 11 May 2020 Subject : Management’s Discussion and Analysis for the First Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
ที่ บช NO. AC. 02/2020 14 May 2020 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M.K. Real Estate Development Plc
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
Exchange of Thailand Dimet (Siam) Public Company Limited “company” would like to notify on qualified opinion from auditor as shown in Noted to Financial Statement due to authorized directors of ASIAN
Discussion and Analysis Quarterly Ending September 30, 2020 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited ( the Company) No. 5
Page 1 No. CMC Sor Lor.012/2019 August 13, 2019 Re: Management Discussion & Analysis for the Period Ended 30 June 2019 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN
Discussion and Analysis Quarterly Ending September 30, 2019 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4